In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer

Retinol molecule was modified to predict the inhibitors of telomerase reverse transcriptase for the treatment of arsenical cancer through in silico study. Telomerase activity is expressed in the cancerous conditions which can be the target for anticancer activity by inhibiting telomerase reverse tra...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kipchu Tshering, Mir Misbahuddin
Формат: Artigo
Язык:Inglês
Опубликовано: Bangabandhu Sheikh Mujib Medical University 2016-09-01
Серии:Bangabandhu Sheikh Mujib Medical University Journal
Предметы:
Arsenic
Cancer
In silico
Molecular docking
Retinol
Telomerase reverse transcriptase
Online-ссылка:https://www.banglajol.info/index.php/BSMMUJ/article/view/29650
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы